Literature DB >> 8951157

Chronotropic effects of optical isomers of ephedrine and methylephedrine in the isolated rat right atria and in vitro assessment of direct and indirect actions on beta 1-adrenoceptors.

T Kawasuji1, K Koike, H Saito.   

Abstract

Effects of optical isomers of ephedrine (EPH) and methylephedrine (MEP) on the spontaneous beating rate of isolated right atrium of normal and reserpinized rat were investigated to assess direct and indirect actions on beta 1-adrenoceptors. l-EPH (3 x 10(-7) - 3 x 10(-5) M) and d-EPH (10(-6) - 10(-4) M) markedly increased beating rate of rat right atrium. l-MEP (10(-5) - 3 x 10(-4) M) showed slight increase in heart rate. The potency of positive chronotropic effect is l-EPH > d-EPH "l-MEP. l-EPH was about 3 times as potent as d-EPH. In addition, d-MEP (3 x 10(-5) - 3 x 10(-4) M) caused a decrease in heart rate. Positive chronotropic effects of EPH isomers and l-MEP were attenuated by pretreatment with atenolol ( a selective beta 1-adrenoceptor antagonist) or reserpine treatment (8 mg/kg, s.c.). In reserpinized atria, the maximal increase by d-EPH was quite small, and l-MEP decreased heart rate. On the other hand, d-MEP, at 3 x 10(-4) M, did not show antagonist activity against the positive chronotropic effect of isoprenaline (10(-10) - 10(-5) M). These results suggest that l-EPH, d-EPH and l-MEP have beta 1-adrenoceptor agonist activity, while d-MEP is suggested to have only low or no affinity for beta 1-adrenoceptors. The relatively weak activity of l-MEP is believed to be mainly mediated by released noradrenaline. It is also suggested that d-EPH has very potent noradrenaline-releasing activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8951157     DOI: 10.1248/bpb.19.1423

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  2 in total

1.  Pressor responses to ephedrine are not impaired in dopamine beta-hydroxylase knockout mice.

Authors:  J T Liles; S R Baber; W Deng; J R Porter; C Corll; S N Murthy; S A Thomas; P J Kadowitz
Journal:  Br J Pharmacol       Date:  2006-11-13       Impact factor: 8.739

2.  Use of knockout technology to resolve pharmacological problems.

Authors:  J R Docherty
Journal:  Br J Pharmacol       Date:  2006-11-13       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.